BSI-201
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for BSI-201, covering 2012-08-02 to 2022-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma [Phase 1, Phase 2]